Some healthcare facilities are experiencing stock-outs of lopinavir/ritonavir adult tablets. If other formulations are available (e.g. paediatric tablets or syrup), then these may be used at the equivalent dose.

See the advice from the HIV Clinicians’ Society on how to manage this challenge when there are no alternative formulations of LPV/r.

Please note that if circulars have been distributed in provinces, these need to be adhered to by healthcare workers in the public sector.